Clinical trials
Observational Pulmonary Arterial Hypertension trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2012 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione IRCCS Policlinico San Matteo di Pavia | 2 |
| AOP Orphan Pharmaceuticals AG | 1 |
| Alessandra Gorini | 1 |
| Ente Ospedaliero Ospedali Galliera | 1 |
| Fatebenefratelli Hospital | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Janssen-Cilag S.p.A. | 1 |
| Technische Universität Dresden | 1 |
| University of Campania Luigi Vanvitelli | 1 |
| iPHNET (italian Pulmonary Hypertension NETwork) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 11 |
| Aortic Valve Disease | 1 |
| COVID-19 | 1 |
| Cardiomyopathies | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Coronary Artery Disease | 1 |
| Eisenmenger Complex | 1 |
| Heart Defects, Congenital | 1 |
| Heart Failure | 1 |
| Hypertension, Pulmonary | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.